Sustainable Endotoxin Testing in China: rCR Chromogenic Assay by Leading Suppliers & Factory Solutions
Products Features
The Recombinant Cascade Reagent (RCR) represents a significant advancement in bacterial endotoxin testing, serving as a sustainable and highly specific recombinant alternative to traditional Limulus Amoebocyte Lysate (LAL). Its development aligns with modern ethical and regulatory expectations while maintaining robust analytical performance.
Sustainable & Animal-Free
By utilizing recombinant technology, RCR eliminates dependency on horseshoe crab blood, thereby supporting conservation efforts and promoting animal welfare without compromising reagent supply. The recombinant cascade—comprising recombinant Factor C, Factor B, and proclotting enzyme—ensures a reaction mechanism that closely mirrors that of native LAL.
Enhanced Specificity
Unlike native LAL reagents, RCR is not activated by (1→3)-β-D-glucans, which are known to cause false-positive results in certain samples. This attribute significantly improves test accuracy and reliability in complex pharmaceutical matrices.
Regulatory Compliance
The adoption of RCR is supported by emerging pharmacopeial standards, such as the proposed USP <86> chapter titled “Bacterial Endotoxins Test Using Recombinant Reagents,” facilitating its smooth integration into regulated laboratory environments.
Proven Performance
RCR's applicability has been demonstrated across a range of real-world pharmaceutical products, exhibiting excellent sample compatibility and producing results comparable to traditional LAL-based methods.
What is Recombinant Cascade Reagent (RCR)?
RCR is a sustainable and highly specific recombinant alternative to traditional Limulus Amoebocyte Lysate (LAL) used for bacterial endotoxin testing in the pharmaceutical industry.
How does RCR support animal welfare?
RCR is produced entirely animal-free using recombinant technology. This eliminates the dependency on horseshoe crab blood, helping to protect marine wildlife and support conservation efforts.
Does RCR function the same way as traditional LAL?
Yes. RCR contains recombinant Factor C, Factor B, and proclotting enzyme. This combination ensures a reaction mechanism that closely mirrors native LAL, providing a high correlation with traditional methods.
How does RCR prevent false-positive results?
Unlike native LAL, RCR is designed to be highly specific and is not activated by (1→3)-β-D-glucans, which are common sources of false-positives in complex pharmaceutical samples.
Is RCR accepted under pharmaceutical regulatory standards?
Yes, the transition to RCR is facilitated by emerging pharmacopeial standards, including the proposed USP <86> chapter focused on endotoxin testing with recombinant reagents.
Can RCR be used for testing complex pharmaceutical products?
Yes, RCR has demonstrated excellent compatibility and comparable performance to traditional LAL across a wide variety of real-world pharmaceutical products.